Effects of Native and Myeloperoxidase-Modified Apolipoprotein A-I on Reverse Cholesterol Transport and Atherosclerosis in Mice
出版年份 2014 全文链接
标题
Effects of Native and Myeloperoxidase-Modified Apolipoprotein A-I on Reverse Cholesterol Transport and Atherosclerosis in Mice
作者
关键词
-
出版物
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 34, Issue 4, Pages 779-789
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2014-01-10
DOI
10.1161/atvbaha.113.303044
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rapid regression of atherosclerosis with MTP inhibitor treatment
- (2013) Bernd Hewing et al. ATHEROSCLEROSIS
- Function and Distribution of Apolipoprotein A1 in the Artery Wall Are Markedly Distinct From Those in Plasma
- (2013) Joseph A. DiDonato et al. CIRCULATION
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
- (2013) et al. EUROPEAN HEART JOURNAL
- Why Targeting HDL Should Work as a Therapeutic Tool, but Has Not
- (2013) Mary G. Sorci-Thomas et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Local proliferation dominates lesional macrophage accumulation in atherosclerosis
- (2013) Clinton S Robbins et al. NATURE MEDICINE
- HDL Induces the Expression of the M2 Macrophage Markers Arginase 1 and Fizz-1 in a STAT6-Dependent Process
- (2013) Marie Sanson et al. PLoS One
- High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
- (2012) Edward A. Fisher et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies
- (2012) Stephen J. Nicholls et al. CARDIOVASCULAR DRUGS AND THERAPY
- HDL and Cardiovascular Risk
- (2012) Bernd Hewing et al. CIRCULATION RESEARCH
- Rationale for cholesteryl ester transfer protein inhibition
- (2012) Bernd Hewing et al. CURRENT OPINION IN LIPIDOLOGY
- Preclinical mouse models and methods for the discovery of the causes and treatments of atherosclerosis
- (2012) Bernd Hewing et al. Expert Opinion on Drug Discovery
- The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Trial
- (2012) Stephen J. Nicholls JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events
- (2012) Erin D. Michos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long term
- (2012) Borja Ibanez et al. THROMBOSIS AND HAEMOSTASIS
- Reversal of Hyperlipidemia With a Genetic Switch Favorably Affects the Content and Inflammatory State of Macrophages in Atherosclerotic Plaques
- (2011) Jonathan E. Feig et al. CIRCULATION
- Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
- (2011) Katey J. Rayner et al. JOURNAL OF CLINICAL INVESTIGATION
- Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies
- (2011) Eline Van Craeyveld et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Statins Promote the Regression of Atherosclerosis via Activation of the CCR7-Dependent Emigration Pathway in Macrophages
- (2011) Jonathan E. Feig et al. PLoS One
- HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells
- (2011) J. E. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo
- (2010) Christina A. Bursill et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
- (2010) Laurent Yvan-Charvet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
- (2010) Ron Waksman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Modification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle
- (2009) Arundhati Undurti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor
- (2009) Chongren Tang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages
- (2008) Laurent Yvan-Charvet et al. CIRCULATION
- Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
- (2008) James A. Shaw et al. CIRCULATION RESEARCH
- Increased Cellular Free Cholesterol in Macrophage-specificAbca1Knock-out Mice Enhances Pro-inflammatory Response of Macrophages
- (2008) Xuewei Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapid Change in Plaque Size, Composition, and Molecular Footprint After Recombinant Apolipoprotein A-IMilano (ETC-216) Administration
- (2008) Borja Ibanez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dose-Related Effects of Repeated ETC-216 (Recombinant Apolipoprotein A-IMilano/1-Palmitoyl-2-Oleoyl Phosphatidylcholine Complexes) Administrations on Rabbit Lipid-Rich Soft Plaques
- (2008) Cinzia Parolini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started